Pfizer Limited AGM 2026: ₹75 dividend, key dates

What Pfizer Limited has announced

Pfizer Limited (BSE: 500680, NSE: PFIZER) has filed disclosures around its 75th Annual General Meeting (AGM), including the AGM notice, its Annual Report for FY 2025-26, and the Business Responsibility and Sustainability Report (BRSR) Core. The company has scheduled the AGM for Tuesday, July 28, 2026, and will conduct it through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in line with applicable circulars issued by the Ministry of Corporate Affairs (MCA) and SEBI.

The intimation references an earlier letter dated May 12, 2026, when the Board approved key items, including the AGM date and a final dividend recommendation. The company’s communication also includes shareholder participation details, such as remote e-voting dates and eligibility cut-offs.

AGM schedule, time, and meeting mode

Pfizer Limited’s 75th AGM is set for Tuesday, July 28, 2026 at 3:00 p.m. IST. The company has opted for a VC/OAVM format, which has become a standard approach for listed companies when permitted by regulators.

The notice indicates that the AGM will be used to transact ordinary business as well as specific special business items. Ordinary business includes adoption of audited financial statements for the year ended March 31, 2026, and consideration of the final dividend.

Final dividend proposal: ₹75 per share for FY26

The Board of Directors, at its meeting held on May 12, 2026, has recommended a final dividend of ₹75 per equity share of face value ₹10 each (750%) for the financial year ended March 31, 2026. The proposed dividend is subject to shareholder approval at the 75th AGM.

The disclosure also states the total dividend amount is ₹343.11 crore. If shareholders approve the proposal at the AGM, Pfizer Limited has indicated that the dividend will be paid on or after August 4, 2026, to eligible shareholders.

Record date, dividend payment timing, and shareholder eligibility

For dividend eligibility, Pfizer Limited has fixed Friday, July 17, 2026 as the record date. The notice specifies that the dividend, if declared, will be paid to:

• Beneficial owners of shares held in dematerialised form, based on the data available as of the close of business hours on July 17, 2026.
• Members holding shares in physical form, based on the Register of Members maintained as of the close of business hours on July 17, 2026.

The company has stated the payout timeline as on or after August 4, 2026, assuming shareholder approval.

Remote e-voting window and cut-off date for voting

Pfizer Limited has informed shareholders that remote e-voting will be available ahead of the AGM. As per the filing:

• Remote e-voting commences on Friday, July 24, 2026 at 9:00 a.m. IST
• Remote e-voting ends on Monday, July 27, 2026 at 5:00 p.m. IST

The cut-off date for determining eligibility to vote is Tuesday, July 21, 2026 (close of business hours). Shareholders whose names appear in the Register of Members or in the Register of Beneficial Owners maintained by the depositories as of that cut-off date can use the voting facility.

FY26 performance snapshot disclosed

Alongside AGM-related disclosures, the filing includes key FY26 financial highlights. Pfizer Limited reported a 10.4% increase in revenue from operations to ₹2,519.65 crore for the year ended March 31, 2026. Another stated figure in the disclosure set summarises revenue at ₹2,520 crore for FY26, reflecting rounding.

Profit after tax is stated at ₹722.43 crore. The disclosure set also notes that net profit declined to ₹722.43 crore due to exceptional items, as presented in the source material.

Items of business: financial statements, director re-appointment, cost auditor fees

The AGM agenda covers both ordinary and special business items disclosed in the notice. Beyond the adoption of audited financial statements and the dividend declaration, shareholders will consider:

• Re-appointment of Mr. P. Rengan, Director liable to retire by rotation.
• Ratification of remuneration payable to M/s Kishore Bhatia & Associates, Cost Accountants, for the financial year ending March 31, 2027.

For the cost auditor item, the remuneration is fixed at ₹11,00,000 plus applicable taxes and out-of-pocket expenses.

Compliance and filings: what the company submitted

The disclosures state that the AGM notice and annual report for FY ended March 31, 2026 have been circulated electronically to shareholders and made available through the company’s website and the registrar’s e-voting portal. The company’s exchange intimation includes its NSE identifier as Scrip Symbol: PFIZER.

The filing also mentions submission under SEBI (LODR) requirements and includes the company’s corporate contact points such as contactus.india@pfizer.com and the website www.pfizerltd.co.in.

Key dates and numbers at a glance

Recent dividend data mentioned in the disclosure set

The source material also lists certain historical cash dividend entries and dates. These entries appear as separate records in the provided dataset.

Why these disclosures matter for shareholders

For investors tracking Pfizer Limited, the practical takeaways are the timelines and eligibility dates. The record date (July 17, 2026) determines who can receive the final dividend if it is approved, while the cut-off date (July 21, 2026) determines who can vote on the resolutions.

The agenda also signals what shareholders will be asked to approve, including a significant final dividend recommendation of ₹75 per share, routine director re-appointment by rotation, and ratification of cost auditor remuneration for FY27. The next formal step is the shareholder vote at the AGM on July 28, 2026, after which the company has indicated dividend payment would follow on or after August 4, 2026.